Company intelligence / Profile preview

Natumin Pharma

Habo, Jönköping, Swedennatumin.se ↗

Ownership: Private
Development stage: Other

Overview

Natumin Pharma develops and manufactures beverages, dietary supplements, dermatological products, cosmetics, medical devices, and traditional herbal medicines. The company operates a GMP-certified production plant in Sweden. It serves both as an independent contract manufacturer for group companies/external customers and markets its own brands. In May 2022 it was acquired by Humble Group. The company emphasizes quality management aligned with regulatory requirements.

Therapeutic areas: DermatologyOther
Modalities: Small moleculeMedical deviceCosmeceutical
Industry: Food & Nutrition

Partnerships

Distribution partnership with Ester C-company for vitamin C products in Europe

Beyond the preview

Go deeper on Natumin Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natumin Pharma.

Explore the full profile